69097-262 : Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC69097-262
Labeler: Cipla USA Inc.
Product Type: Human Prescription Drug
Drug Name:  Topotecan Hydrochloride
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA091199
Rev. Date: 


NDC Package Codes:

  • 69097-262-67: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (69097‑262‑67) > 4 ML IN 1 VIAL, SINGLE‑DOSE
  • 69097-262-68: 5 VIAL, SINGLE‑DOSE IN 1 CARTON (69097‑262‑68) > 4 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Topotecan Hydrochloride

Dosage Strength:

  • 4 mg/4mL

Pharmaceutical Classes:

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0069-0075 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc.
  • 16729-151 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc.
  • 25021-206 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 25021-824 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 45963-615 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Actavis Pharma, Inc.
  • 55390-370 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 62756-023 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Sun Pharmaceutical Industries Limited
  • 63323-762 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by App Pharmaceuticals, LLC
  • 66435-410 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, for Solution by Three Rivers Pharmaceuticals, LLC.
  • 67457-474 Topotecan Hydrochloride 4 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69097-262 QR Code

< Prev: 69097-261Next: 69097-263 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 December 2018.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA